NR0B2 and metabolic dysfunction-associated steatohepatitis: Based on earlier observations that free cholesterol loading on hepatocytes or the dietary cholesterol component is sufficient to trigger both hepatic TG accumulation and inflammation (31, 39), we suggest that the reduction of hepatic cholesterol by Shp deletion may play a critical role in the attenuation of the NASH phenotype manifested by the two diet challenges.